Scope
Epidemiologic studies suggest a link between the incidence of food allergy and the consumption of dietary advanced glycation end‐products (AGEs). However, the pathogenic role of dietary AGEs in food allergy is largely unknown. This study aims to investigate the effect of allergen‐specific and non‐specific AGEs on the allergenic manifestation of ovalbumin (OVA), a typical food allergen in vivo.
Methods and results
OVA is glycated by methylglyoxal to prepare allergen‐specific AGEs (i.e., OVA‐AGE), and a standard AIN‐93G diet is heated to obtain allergen‐non‐specific AGEs. A BALB/c mouse model orally sensitizes to OVA with different forms of AGEs is established and the outcomes are measured as clinical signs, specific antibodies, type‐2/type‐2 cytokines, immune cell subpopulations, intestinal barrier function, and gut microbiota (GM) composition. The OVA‐AGE which has a lower immunoglobulin E (IgE)‐binding level in vitro does not reduce the allergenicity of OVA but promotes a stronger T helper 2 cells (Th2)‐response than native OVA in vivo. Both forms of AGEs up‐regulate the expression of splenic RAGE and aggravate the destruction of gut barrier and GM dysbiosis, especially when exposes to non‐relevant AGEs.
Conclusion
This study highlights the role of dietary AGEs in food allergy and helps to understand the biological consequences of immune‐toxic compounds in modern diet.